NIH-funded study identifies gene variant as potential drug target
Defying the odds, an individual at high risk for early-onset Alzheimer’s disease remained dementia-free for many years beyond what was anticipated. A study funded in part by the National Institute on Aging (NIA), part of the National Institutes of Health, led researchers to suggest that a gene variant may be the key, perhaps providing a new direction toward developing a treatment.
The research focused on the case of a woman who carried a gene mutation known to cause early-onset Alzheimer’s. However, she did not develop signs of the disease until her seventies, nearly three decades after her expected age of onset. The researchers suspect that she may have been protected because in addition to the gene mutation causing early-onset Alzheimer’s in her family, she also had two copies of the APOE3 Christchurch (APOE3ch) gene variant. Findings of this case study as published in Nature Medicine suggest that two copies of the APOE3ch variant, named after Christchurch, New Zealand where it was first identified, may protect against Alzheimer’s.
“Sometimes close analysis of a single case can lead to discovery that could have broad implications for the field,” said NIA Director Richard J. Hodes, M.D. “We are encouraged that as part of our wide array of studies, this research in the unique genetic makeup of an exceptional individual can reveal helpful information.”
Early-onset Alzheimer’s disease is rare, representing less than 10% of all people who have Alzheimer’s. It typically occurs between a person’s 30s to mid-60s. Risk for both early- and late-onset Alzheimer’s disease is affected by genetic factors.
For the study, researchers led by investigators at Massachusetts General Hospital, Boston, in collaboration with the University of Antioquia, Medellin, Colombia, Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, and Banner Alzheimer’s Institute, Phoenix, looked at genetic data from a Colombian family with more than 6,000 living members. Family members who carry a rare gene mutation called Presenilin 1 (PSEN1) E280A, have a 99.9% risk of developing early-onset Alzheimer’s disease.
The researchers confirmed that the woman in this case carried the PSEN1 E280A mutation, which caused early-onset Alzheimer’s in her other family members. However, she also had two copies of the APOE3ch gene variant, while no other affected family member carried two copies of this variant. Affected family members develop Alzheimer’s in their 40s, but she remained disease free until her 70s. Imaging tests showed that the woman had only minor neurodegeneration. She did have large amounts of amyloid protein deposits, a hallmark of Alzheimer’s disease, in her brain. But the amount of tau tangles, another hallmark of the disease, and the one more correlated with how thinking and memory are affected, was relatively low.
Experiments as part of the study showed that the APOE3ch variant may reduce the ability of APOE to bind to certain sugars called heparan sulphate proteoglycans (HSPG). APOE binding to HSPG has been implicated as one mechanism that may contribute to the amyloid and tau protein deposits that destroy the brain. The research suggests that a drug or gene therapy that could reduce APOE and HSPG binding has the potential to be a new way to treat or prevent Alzheimer’s disease.
The Latest on: Alzheimer’s
via Google News
The Latest on: Alzheimer’s
- Genetic Variant Could Boost Precision Medicine for Alzheimer’s on November 18, 2019 at 6:59 am
November 18, 2019 - Researchers at Massachusetts General Hospital (MGH) have discovered that certain genetic variants may help protect against Alzheimer’s disease. Their findings could hold important ...
- Alzheimer's can be hard to discuss. This ad campaign hopes to simplify that. on November 18, 2019 at 6:01 am
Looking to better understand Alzheimer's and its deep, emotional impact? A new ad campaign, structured as a podcast miniseries and made in collaboration between the Alzheimer's Association, the Ad ...
- Kastner North America Brings Creativity & Action For Alzheimer's Awareness Month on November 18, 2019 at 6:00 am
LOS ANGELES, Nov. 18, 2019 /PRNewswire/ -- Los Angeles advertising agency, Kastner North America, widely known in the industry for its innovative campaigns, announced today a concept more impactful ...
- Alzheimer’s Association seeks public policy volunteers for Buncombe and Henderson counties on November 18, 2019 at 5:44 am
Press release from the Alzheimer’s Association Western Carolina Chapter: The Alzheimer’s Association – Western Carolina Chapter is expanding its base of public policy volunteers in Buncombe and ...
- Professor Rudolph E. Tanzi, Ph.D., World Renowned Alzheimer's Researcher, Joins Jupiter Orphan Therapeutics on November 18, 2019 at 4:38 am
"Dr. Tanzi's well documented knowledge, network and reputation in the field of neurological diseases with a focus on Alzheimer's Disease (AD) is a very valuable and exciting addition to our company.
- Alzheimer's Drugs Market In-Depth Analysis & Future Growth Forecast to 2025 on November 17, 2019 at 9:37 pm
Nov 18, 2019 (Heraldkeepers) -- People suffering from Alzheimer's and dementia do not get proper access to the healthcare infrastructure to diagnose and treat the disease. For instance according to ...
- Woman with Dementia and Alzheimer’s found, Round Rock police say on November 17, 2019 at 4:40 pm
ROUND ROCK, Texas (KXAN) — Round Rock police says a woman with Dementia and Alzheimer’s was found after she walked out of a hospital and did not return on Sunday. Police tweeted that Patricia Coleman, ...
- Q&A: Brightview Senior Living director talks initiatives, fundraising, education during Alzheimer’s Awareness month on November 17, 2019 at 12:10 pm
November has been recognized as Alzheimer’s Awareness month in the United States since 1983 in honor of the millions of people who have the neurological disease and the millions who care for a loved ...
- How to live a full life with early Alzheimer's on November 17, 2019 at 3:00 am
Once that dreaded word -- Alzheimer's -- is uttered about you by a physician, it is time to take immediate action. First, be sure to take any helpful drugs your physician prescribes. They can help ...
- Missing man last seen in Greenacres has Alzheimer's on November 16, 2019 at 1:42 pm
GREENACRES — The Palm Beach County Sheriff’s Office is asking the public to help find a 71-year-old man with Alzheimer’s. William Restrepo was last seen near Stuart Circle, just south of Lake Worth ...
via Bing News